Zhongchao (ZCMD) Debt to Equity (2018 - 2024)

Zhongchao (ZCMD) reported Debt to Equity of $0.02 for Q4 2024, down 13.5% year-over-year from $0.03 in Q1 2024, and down 13.5% quarter-over-quarter from $0.03 in Q4 2023.

Zhongchao (ZCMD) Debt to Equity (2018 - 2024) Analysis & Trends

Zhongchao (ZCMD) has 4 years of Debt to Equity data on file, last reported at $0.02 in Q4 2024.

  • Debt to Equity for Q4 2024 came in at $0.02, down 13.5% year-over-year; the trailing twelve-month figure through Dec 2024 was $0.02 (down 13.5% YoY), and the FY2024 annual result was $0.02, down 13.5% from the prior year.
  • Debt to Equity declined to $0.02 in Q4 2024 per ZCMD's latest filing, from $0.03 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.03 in Q4 2023 and troughed at $0.02 in Q4 2022.
  • A 3-year average of $0.02 and a median of $0.02 in 2024 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2023 and 2024: Debt to Equity increased 16.15% in 2023, then decreased 13.5% in 2024.
  • A 3-year view of Debt to Equity shows it stood at $0.02 in 2022, then advanced by 16.15% to $0.03 in 2023, then decreased by 13.5% to $0.02 in 2024.
  • Business Quant data shows ZCMD's Debt to Equity at $0.02 in Q4 2024, $0.03 in Q4 2023, and $0.02 in Q4 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn -
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 1.26
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 0.46
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn -
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn -
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn -
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 0.37
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn -
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn -
10 Zhongchao - - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.02
Dec 31, 2023 0.03
Dec 31, 2022 0.02
Dec 31, 2018 0.06